...
首页> 外文期刊>Journal of Veterinary Pharmacology and Therapeutics >Pharmacokinetics and physiological effects of repeated oral administrations of tramadol in horses.
【24h】

Pharmacokinetics and physiological effects of repeated oral administrations of tramadol in horses.

机译:反复口服曲马多在马中的药代动力学和生理作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study evaluated the pharmacokinetics and physiological effects of tramadol during repeated oral administrations in horses. Nine adult healthy horses were administered tramadol at 5 and 10 mg/kg orally every 12 h for 5 days in a randomized, crossover design with a 3-week washout between treatments. Plasma concentrations of tramadol, O- and N-desmethyltramadol (M1 and M2) were measured using Liquid-Chromatography-Mass Spectrometry at predetermined time points following each tramadol administration. Cardiovascular, respiratory and gastrointestinal physiological variables were monitored and adverse events were recorded. Data were analysed with two-way repeated measures ANOVA or Kruskal-Wallis one-way ANOVA on ranks with P<0.05 considered statistically significant. There were no significant effects of tramadol on the physiological variables. One horse receiving 10 mg/kg tramadol developed mild colic. Following tramadol at 5 and 10 mg/kg, respectively, maximum plasma concentrations (Cmax) of tramadol ranged from 82-587 and 127-1280 ng/mL, nonconjugated M1 ranged from 2.51-26.7 and 4.88-34.3 ng/mL, and nonconjugated M2 from 12.5-356 and 35.4-486 ng/mL. Corresponding minimum plasma concentrations (Cmin) of tramadol at 12 h following each dose ranged from 0.8-24 and 3-117 ng/mL. Tramadol accumulated considerably over time, more markedly when given at 10 mg/kg than at 5 mg/kg (accumulation indexes of 3.51 and 1.73 respectively). There was no accumulation of M1 but substantial accumulation of M2. In conclusion, there was accumulation and increase in exposure to tramadol and M2, but not M1, during repeated oral administrations in horses.
机译:这项研究评估了在反复口服马匹中曲马多的药代动力学和生理作用。随机,交叉设计,每12 h口服5和10 mg / kg剂量的9只成年健康马曲马多,治疗5天,治疗间隔3周。每次服用曲马多后的预定时间点,使用液相色谱-质谱法测定曲马多,O-和N-去甲基曲马多的血浆浓度(M1和M2)。监测心血管,呼吸和胃肠道的生理变量,并记录不良事件。数据采用两次重复测量ANOVA或Kruskal-Wallis单向ANOVA进行分析,等级P <0.05被认为具有统计学意义。曲马多对生理变量没有显着影响。一匹接受10 mg / kg曲马多的马发展为轻度绞痛。分别以5和10 mg / kg的曲马多给药后,曲马多的最大血浆浓度(C max )范围为82-587和127-1280 ng / mL,未结合的M1范围为2.51-26.7和4.88 -34.3 ng / mL,以及未结合的M2(12.5-356和35.4-486 ng / mL)。每次剂量后12 h,曲马多的相应最低血浆浓度(C min )在0.8-24和3-117 ng / mL之间。曲马多随时间累积大量,以10 mg / kg给药比以5 mg / kg给药更显着(累积指数分别为3.51和1.73)。没有M1的积累,但是有M2的大量积累。总之,在马中反复口服给药期间,曲马多和M2而不是M1的积累和暴露增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号